报告人：Prof. Rose Amal (School of Chemical Engineering, UNSW, Sydney, Australia)
Professor Rose Amal is a UNSW Scientia Professor and an ARC Laureate Fellow. Prof. Rose Amal is a chemical engineer and the leader of the Particles and Catalysis Research Group. Previously she was also the Director of the ARC Centre of Excellence for Functional Nanomaterials (2010-2013). Professor Rose Amal has received numerous prestigious awards including: being listed in the Australia's Top 100 Most Influential Engineers in 2012-2015, the ExxonMobil Award (2012), the Judy Raper Women in Engineering Leadership Award (2012), the NSW Science and Engineering Award - Emerging Research (2011), the UNSW Scientia Professor (2009), the Freehills Award (2008), and the UNSW Vice Chancellors Award for Research Supervision Excellence (2003). She is a Fellow of Australian Academy of Technological Sciences and Engineering (FTSE) and Fellow of Australian Academy of Science (FAA). Professor Rose Amal is recognised as a pioneer and leading authority in the fields of fine particle technology, photocatalysis and functional nanomaterials having made significant contributions to these related areas of research over the past 15 years. Her research contributions span from fundamental chemistry to applied chemical engineering fields; from material science and nano-research to a specialised photochemistry field. Her current research focuses on designing nanomaterials for solar and chemical energy conversion applications (including photocatalysis for water and air purification, water splitting, development of indoor self-cleaning materials, low temperature catalytic reactions) and engineering systems for solar induced processes, using the sun’s energy as a clean fuel source.
Water is a critical raw material in pharmaceutical manufacturing; consistent and high-quality water supplies are required for a range of operations including production, material processing, and cooling. Wastewaters generated in different processes in the manufacture of pharmaceuticals and drugs contain a wide variety of compounds. No single technology can completely remove pharmaceutical contaminants from the wastewaters. This presentation provides an overview of processes that are commonly used as well as presenting advanced and hybrid wastewater treatment technologies to treat wastewaters from pharmaceutical industries to minimise Active Pharmaceutical Ingredients (API) in our waterways.